These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 38157651)

  • 21. Fetal growth restriction and intra-uterine growth restriction: guidelines for clinical practice from the French College of Gynaecologists and Obstetricians.
    Vayssière C; Sentilhes L; Ego A; Bernard C; Cambourieu D; Flamant C; Gascoin G; Gaudineau A; Grangé G; Houfflin-Debarge V; Langer B; Malan V; Marcorelles P; Nizard J; Perrotin F; Salomon L; Senat MV; Serry A; Tessier V; Truffert P; Tsatsaris V; Arnaud C; Carbonne B
    Eur J Obstet Gynecol Reprod Biol; 2015 Oct; 193():10-8. PubMed ID: 26207980
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of uterine Doppler on midbrain growth and cortical development in late onset fetal growth restricted fetuses: a prospective cross-sectional study.
    Mappa I; Marra MC; Patelli C; Lu JLA; D'Antonio F; Rizzo G
    J Matern Fetal Neonatal Med; 2024 Dec; 37(1):2318604. PubMed ID: 38373847
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of Causes and Results of Fetal Growth in Utero Caused by Genetic Factors Detected by Ultrasound.
    Yu M; Liu Y; Wang L
    Contrast Media Mol Imaging; 2022; 2022():3703132. PubMed ID: 36105440
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tadalafil Treatment of Mice with Fetal Growth Restriction and Preeclampsia Improves Placental mTOR Signaling.
    Tanaka K; Tanaka H; Tachibana R; Yoshikawa K; Kawamura T; Takakura S; Takeuchi H; Ikeda T
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163395
    [TBL] [Abstract][Full Text] [Related]  

  • 25. TADAFER II: Tadalafil treatment for fetal growth restriction - a study protocol for a multicenter randomised controlled phase II trial.
    Umekawa T; Maki S; Kubo M; Tanaka H; Nii M; Tanaka K; Osato K; Kamimoto Y; Tamaru S; Ogura T; Nishimura Y; Kodera M; Minamide C; Nishikawa M; Endoh M; Kimura T; Kotani T; Nakamura M; Sekizawa A; Ikeda T;
    BMJ Open; 2018 Oct; 8(10):e020948. PubMed ID: 30381311
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tadalafil Improves L-NG-Nitroarginine Methyl Ester-Induced Preeclampsia With Fetal Growth Restriction-Like Symptoms in Pregnant Mice.
    Yoshikawa K; Umekawa T; Maki S; Kubo M; Nii M; Tanaka K; Tanaka H; Osato K; Kamimoto Y; Kondo E; Ikemura K; Okuda M; Katayama K; Miyoshi T; Hosoda H; Ma N; Yoshida T; Ikeda T
    Am J Hypertens; 2017 Dec; 31(1):89-96. PubMed ID: 28992178
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Early-onset fetal growth restriction treated with the long-acting phosphodiesterase-5 inhibitor tadalafil: a case report.
    Sakamoto M; Osato K; Kubo M; Nii M; Tanaka H; Murabayashi N; Umekawa T; Kamimoto Y; Ikeda T
    J Med Case Rep; 2016 Nov; 10(1):317. PubMed ID: 27821175
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pravastatin plus L-arginine prevents adverse pregnancy outcomes in women with uteroplacental vascular dysfunction.
    Jurisic A; Jurisic Z; Lefkou E; Girardi G
    Vascul Pharmacol; 2021 Apr; 137():106824. PubMed ID: 33249273
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of Sildenafil and Tadalafil for Reversing Constriction of Fetal Arteries in a Human Placenta Perfusion Model.
    Walton RB; Reed LC; Estrada SM; Schmiedecke SS; Villazana-Kretzer DL; Napolitano PG; Ieronimakis N
    Hypertension; 2018 Jul; 72(1):167-176. PubMed ID: 29735634
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cardiac function and tadalafil used for treating fetal growth restriction in pregnant women without cardiovascular disease.
    Tanaka K; Tanaka H; Maki S; Kubo M; Nii M; Magawa S; Hatano F; Tsuji M; Osato K; Kamimoto Y; Umekawa T; Ikeda T
    J Matern Fetal Neonatal Med; 2019 Aug; 32(15):2460-2462. PubMed ID: 29415591
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ultrasonographic assessment of abnormal fetal growth related to uteroplacental-fetal biometrics and Doppler (U-AID) indices: Protocol for multicenter retrospective cohort study trial.
    Choi ES; Lee H; Lee SJ; Jung YM; Kim HY; Lee SM; Lee KA; Seol HJ; Ko HS; Na SH; Kwak DW; Hwang HS; Choi S; Hong SC; Won HS; Kim SY; Kim HJ; Ahn KH
    PLoS One; 2024; 19(2):e0298060. PubMed ID: 38359058
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prediction of delivery of small-for-gestational-age neonates and adverse perinatal outcome by fetoplacental Doppler at 37 weeks' gestation.
    Triunfo S; Crispi F; Gratacos E; Figueras F
    Ultrasound Obstet Gynecol; 2017 Mar; 49(3):364-371. PubMed ID: 27241184
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ophthalmic artery Doppler and biomarkers of impaired placentation at 36 weeks' gestation in pregnancies with small fetuses.
    Arechvo A; Wright A; Nobile Recalde A; Liandro R; Charakida M; Nicolaides KH
    Ultrasound Obstet Gynecol; 2024 Mar; 63(3):358-364. PubMed ID: 37902727
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of placental oxygenation in fetal growth restriction using blood oxygen level-dependent magnetic resonance imaging.
    Magawa S; Nii M; Enomoto N; Takakura S; Maki S; Tanaka H; Ishida M; Kondo E; Sakuma H; Ikeda T
    Placenta; 2022 Aug; 126():40-45. PubMed ID: 35750000
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tadalafil treatment in mice for preeclampsia with fetal growth restriction has neuro-benefic effects in offspring through modulating prenatal hypoxic conditions.
    Tachibana R; Umekawa T; Yoshikawa K; Owa T; Magawa S; Furuhashi F; Tsuji M; Maki S; Shimada K; Kaneda MK; Nii M; Tanaka H; Tanaka K; Kamimoto Y; Kondo E; Kato I; Ikemura K; Okuda M; Ma N; Miyoshi T; Hosoda H; Endoh M; Kimura T; Ikeda T
    Sci Rep; 2019 Jan; 9(1):234. PubMed ID: 30659198
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vivo assessment of placental and brain volumes in growth-restricted fetuses with and without fetal Doppler changes using quantitative 3D MRI.
    Andescavage N; duPlessis A; Metzler M; Bulas D; Vezina G; Jacobs M; Iqbal SN; Baschat A; Limperopoulos C
    J Perinatol; 2017 Dec; 37(12):1278-1284. PubMed ID: 28837138
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tadalafil alleviates preeclampsia and fetal growth restriction in RUPP model of preeclampsia in mice.
    Sekimoto A; Tanaka K; Hashizume Y; Sato E; Sato H; Ikeda T; Takahashi N
    Biochem Biophys Res Commun; 2020 Jan; 521(3):769-774. PubMed ID: 31703840
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Placental magnetic resonance imaging T2* measurements in normal pregnancies and in those complicated by fetal growth restriction.
    Sinding M; Peters DA; Frøkjaer JB; Christiansen OB; Petersen A; Uldbjerg N; Sørensen A
    Ultrasound Obstet Gynecol; 2016 Jun; 47(6):748-54. PubMed ID: 26041014
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Infant outcome after active management of early-onset fetal growth restriction with absent or reversed umbilical artery blood flow.
    Morsing E; Brodszki J; Thuring A; Maršál K
    Ultrasound Obstet Gynecol; 2021 Jun; 57(6):931-941. PubMed ID: 32862450
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Placental growth factor and fetoplacental Doppler indices in combination predict preterm birth reliably in pregnancies complicated by fetal growth restriction.
    Hong J; Crawford K; Cavanagh E; da Silva Costa F; Kumar S
    Ultrasound Obstet Gynecol; 2024 May; 63(5):635-643. PubMed ID: 37820083
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.